Jane Street’s Franklin Genomic Advancements ETF HELX Stock Holding History
Bought
Maintained
Sold
Other funds holding HELX
BFCFSI
Jane Street's HELX Position: Q3 2026 in Review
Jane Street opened a new position in Franklin Genomic Advancements ETF (HELX) in Q3 2026: 71,570 shares worth $3.19M. The stake represents ﹤0.01% of the portfolio and ranks #4396 among its holdings. This is a return to the name: Jane Street previously reported a position in HELX as recently as Q1 2025.
Jane Street first reported a position in HELX in Q3 2020 and has held it in 17 quarters since. The position peaked at $5.54M in Q4 2021. 8 funds tracked by Wall St. Rank hold HELX as of Q3 2026.
- Jane Street held 71,570 shares of Franklin Genomic Advancements ETF worth $3.19M as of Q3 2026.
- Franklin Genomic Advancements ETF was a new Jane Street position in Q3 2026.
- Franklin Genomic Advancements ETF made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #4396 holding.
- Jane Street first reported a position in Franklin Genomic Advancements ETF in Q3 2020 and has held it in 17 quarters since.
- Jane Street's Franklin Genomic Advancements ETF position peaked at $5.54M in Q4 2021.
- 8 funds tracked by Wall St. Rank held Franklin Genomic Advancements ETF as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.